James Mulé

22PUBLICATIONS
113CO-AUTHORS
Immunogenetics (incl. genetic immunology)Predictive and prognostic markersMedical infection agents (incl. prions)Tumour immunologyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jan 10, 2026
The Myeloid Biomarker <i>MS4A6A</i> Drives an Immunosuppressive Microenvironment in Glioblastoma via Activation of the PGE2 Signaling Axis.

Jianan Chen, Qiong Wu, Anders E Berglund

|Nov 03, 2025
Chemokine/cytokine-releasing biomaterials induce in situ tertiary lymphoid-like structures and enhance antitumor immunity.

Rana Falahat, James J Mulé

|May 23, 2025
Facts and Hopes: Toward the Next Quantum Leap in Melanoma.

Keith T Flaherty, Andrew E Aplin, Michael A Davies

Pageof 4